SetPoint’s CEO Simhambhatla gives DT Minn preview on bringing neurotechnologies to new markets

About this episode

Murthy Simhambhatla discusses SetPoint Medical's innovations in neurotechnologies and their upcoming plans.

In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel. As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO. This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations. We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/ Finally, MassDevice Editor Chris…

People in this episode

Host: DeviceTalks Weekly

Guests: Murthy Simhambhatla, Saul Marquez, Chris Newmarker

Topics covered

• neurotechnologies
• MedTech
• FDA approval
• vagal stimulator
• health tech
• market research

Keywords

• SetPoint Medical
• neurotechnologies
• vagal stimulator
• FDA approval
• MedTech
• health tech
• DeviceTalks Minnesota

Sponsors

DeviceTalks Minnesota

Mentioned in this episode

Organizations: SetPoint Medical, Outcome Rocket, MassDevice, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, CathWorks

More episodes of DeviceTalks Podcast Network

• Intuitive's Hutton on Why the Surgical Robotics Leader Is Taking Aim at Cardiac Surgery Again · June 12, 2026 · 1h 2m
• Lisa Earnhardt on Abbott’s Innovation Strategy and the Future of Patient-Centered Care · June 5, 2026 · 1h 15m
• A Focused View of EDOF™ Technology from a GI Clinician · June 2, 2026 · 34 min
• DeviceTalks Boston Wrap Up with the Editors (and Many Special Guests!) · May 29, 2026 · 35 min
• Axoft is building a BCI success story in Massachusetts; MassMEDIC's Johnson on MedTech’s future · May 22, 2026 · 1h 8m
• High-Stakes Decision-Making is an Art – Boston Scientific, Cryosa, Provation · May 19, 2026 · 1h 8m